Iterum Therapeutics plc financial data

Symbol
ITRM on Nasdaq
Industry
Pharmaceutical Preparations
Location
Fitzwilliam Court, 1 St Floor, Leeson Close, Dublin 2, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Former names
Iterum Therapeutics Ltd (to 5/1/2018)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 150 % -77.1%
Debt-to-equity -598 % -422%
Return On Equity 566 %
Return On Assets -114 % -24.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.7M shares +74.1%
Entity Public Float 13.7M USD -62.7%
Common Stock, Value, Issued 166K USD +27.7%
Weighted Average Number of Shares Outstanding, Basic 16.6M shares +27.9%
Weighted Average Number of Shares Outstanding, Diluted 16.6M shares +27.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 30.6M USD +19.8%
General and Administrative Expense 7.61M USD -12.8%
Operating Income (Loss) -38.3M USD -11.5%
Nonoperating Income (Expense) 10.3M USD +19.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -28M USD +50.5%
Income Tax Expense (Benefit) 382K USD -83.4%
Net Income (Loss) Attributable to Parent -28.3M USD +49.7%
Earnings Per Share, Basic -1.99 USD/shares +56%
Earnings Per Share, Diluted -1.99 USD/shares +56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.98M USD -63.8%
Inventory, Net 0 USD
Assets, Current 13.7M USD -71.3%
Property, Plant and Equipment, Net 38K USD -44.9%
Operating Lease, Right-of-Use Asset 378K USD -76.3%
Intangible Assets, Net (Excluding Goodwill) 432K USD -79.9%
Other Assets, Noncurrent 407K USD -83.1%
Assets 14.2M USD -72.2%
Accounts Payable, Current 822K USD -77.9%
Employee-related Liabilities, Current 1.35M USD -4.12%
Accrued Liabilities, Current 2.26M USD -56.3%
Liabilities, Current 16.8M USD +54.9%
Operating Lease, Liability, Noncurrent 16K USD -98.6%
Other Liabilities, Noncurrent 16K USD -98.6%
Liabilities 25.1M USD -42.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD +96.2%
Retained Earnings (Accumulated Deficit) -473M USD -6.37%
Stockholders' Equity Attributable to Parent -10.9M USD -253%
Liabilities and Equity 14.2M USD -72.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD -36.4%
Net Cash Provided by (Used in) Financing Activities 7.22M USD +2971%
Net Cash Provided by (Used in) Investing Activities 7.21M USD +41.2%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 16.6M shares +27.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.32M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 22K USD -85.5%
Deferred Tax Assets, Valuation Allowance 41.7M USD +14.2%
Operating Lease, Liability 372K USD -75.1%
Depreciation 7K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -28.3M USD +49.8%
Lessee, Operating Lease, Liability, to be Paid 393K USD -76.2%
Property, Plant and Equipment, Gross 363K USD -1.63%
Operating Lease, Liability, Current 356K USD +2.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18K USD -95.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 375K USD -9.42%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +148%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21K USD -86.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 300K USD -25.2%
Deferred Tax Assets, Operating Loss Carryforwards 41.5M USD +15.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 2.02M USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 300K USD +4.17%
Operating Lease, Payments 350K USD -25.5%
Amortization of Intangible Assets 429K USD 0%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%